Proteomics secures Australian patent for endometriosis test

AI Summary

Proteomics International secured an Australian patent for its PromarkerEndo test, a major advancement in diagnosing endometriosis. This patent is a key step in the company's global commercialization strategy for the diagnostic tool.

Proteomics International has locked in a key Australian patent for its PromarkerEndo test, a significant step in its global commercialisation strategy for the endometriosis diagnostic.